Literature DB >> 9440634

Effect of gastrin-17 on lower esophageal sphincter characteristics in man.

J W Straathof1, C B Lamers, A A Masclee.   

Abstract

We studied the effect of gastrin-17 on lower esophageal sphincter (LES) characteristics in man. Nine healthy volunteers participated in two experiments performed in random order during continuous infusion of saline (control) or gastrin-17 (15 pmol/kg/hr). LES pressure (LESP) and transient lower esophageal sphincter relaxations (TLESR), as most the important reflux mechanism, were measured with intraesophageal sleeve manometry combined with pH metry. Infusion of gastrin-17 resulted in plasma gastrin levels comparable to those reached after a mixed meal. During continuous gastrin infusion, LESP decreased significantly (P < 0.05) compared to control. The rate and duration of TLESR was not influenced by gastrin-17. Gastroesophageal reflux and the number of TLESR associated with reflux were significantly (P < 0.05) increased during gastrin infusion. These results suggest that in humans gastrin at physiological postprandial plasma concentrations decreases LESP, does not influence TLESR, but increases the percentage of TLESR associated with reflux.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9440634     DOI: 10.1023/a:1018872814428

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

1.  Hormonal control of gastroesophageal-sphincter strength.

Authors:  D O Castell; L D Harris
Journal:  N Engl J Med       Date:  1970-04-16       Impact factor: 91.245

Review 2.  Effects of hormones on gastrointestinal motility.

Authors:  A Ouyang; S Cohen
Journal:  Med Clin North Am       Date:  1981-11       Impact factor: 5.456

3.  Lower oesophageal sphincter response to gastrin--pharmacological or physiological?

Authors:  J M Henderson; G Lidgard; D H Osborne; D C Carter; R C Heading
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

4.  Lower esophageal sphincter and gastric acid response to intravenous infusions of synthetic human gastrin I heptadecapeptide.

Authors:  G R Freeland; R H Higgs; D O Castell; J E McGuigan
Journal:  Gastroenterology       Date:  1976-10       Impact factor: 22.682

5.  Effect of cholecystokinin on lower oesophageal sphincter pressure and transient lower oesophageal sphincter relaxations in humans.

Authors:  M Ledeboer; A A Masclee; M R Batstra; J B Jansen; C B Lamers
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

6.  Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux.

Authors:  J Dent; R H Holloway; J Toouli; W J Dodds
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

7.  Esophageal function and occurrence of Barrett's esophagus in Zollinger-Ellison syndrome.

Authors:  D B Strader; S B Benjamin; M Orbuch; T A Lubensky; F Gibril; C Weber; V A Fishbeyn; R T Jensen; D C Metz
Journal:  Digestion       Date:  1995       Impact factor: 3.216

8.  [Peptone stimulation of the lower esophageal sphincter in patients with reflux disease].

Authors:  G Lepsien; K Dietrich
Journal:  Z Gastroenterol       Date:  1988-04       Impact factor: 2.000

9.  Gastric distention: a mechanism for postprandial gastroesophageal reflux.

Authors:  R H Holloway; M Hongo; K Berger; R W McCallum
Journal:  Gastroenterology       Date:  1985-10       Impact factor: 22.682

10.  Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome.

Authors:  J B Jansen; C B Lamers
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

View more
  7 in total

1.  Dietary carbohydrate intake, insulin resistance and gastro-oesophageal reflux disease: a pilot study in European- and African-American obese women.

Authors:  S D Pointer; J Rickstrew; J C Slaughter; M F Vaezi; H J Silver
Journal:  Aliment Pharmacol Ther       Date:  2016-09-01       Impact factor: 8.171

2.  Low circulating levels of gastrin-17 in patients with Barrett's esophagus.

Authors:  Pentti Sipponen; Matti Vauhkonen; Timo Helske; Ilpo Kaariainen; Matti Harkonen
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

3.  Prevalence of gastroesophageal reflux disease and its association with Helicobacter pylori infection in chronic renal failure patients and in renal transplant recipients.

Authors:  Ibraheim S Abdulrahman; Abdulaziz A Al-Quorain
Journal:  Saudi J Gastroenterol       Date:  2008-10       Impact factor: 2.485

4.  Laparoscopic Heller's myotomy for achalasia after gastric bypass: A case report.

Authors:  Rhiannon Chapman; Adrianna Rotundo; Nick Carter; Jason George; Andrew Jenkinson; Marco Adamo
Journal:  Int J Surg Case Rep       Date:  2013-01-28

5.  The Effects of Modifying Amount and Type of Dietary Carbohydrate on Esophageal Acid Exposure Time and Esophageal Reflux Symptoms: A Randomized Controlled Trial.

Authors:  Cihang Gu; Timothy Olszewski; Karen L King; Michael F Vaezi; Kevin D Niswender; Heidi J Silver
Journal:  Am J Gastroenterol       Date:  2022-06-21       Impact factor: 12.045

6.  Electroacupuncture to treat gastroesophageal reflux disease: study protocol for a randomized controlled trial.

Authors:  Gajin Han; Jungtae Leem; Hojung Lee; Junhee Lee
Journal:  Trials       Date:  2016-05-17       Impact factor: 2.279

7.  Esophageal Dysmotility in Chronic Hemodialysis Patients After Ingestion of Liquids With Different Viscosities.

Authors:  Clovis Massato Kuwahara; Lucilene Rosa-E-Silva; Altair Jacob Mocelin; Miriam Zebian; Rose Meire Albuquerque Pontes; Roberto Oliveira Dantas
Journal:  Gastroenterology Res       Date:  2011-03-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.